ArticleHuman vaccines & immunotherapeutics2021
Portrayals of 2v, 4v and 9vHPV vaccines on Chinese social media: a content analysis of hot posts on Sina Weibo.
Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Trial
- Feasibility and Acceptability of Pay-it-forward in Increasing Uptake of HPV Vaccination among 15- to 18-Year-Old Girls in China: Pilot RCT Results.Cancer prevention research (Philadelphia, Pa.) · 2025Trial
- Factors affecting caregivers' HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT.PloS one · 2025Trial
- HPV vaccination scenario and parental willingness to pay among girls aged 9-14 y in the Yangtze River Delta, China.Human vaccines & immunotherapeutics · 2026Article
- Study of Human Papillomavirus Vaccine-Related Social Media Content Across Eight Social Media Platforms: Scoping Review of Communication Content, Information Sources, and Analytical Approaches.Journal of medical Internet research · 2026Article
- Human Papillomavirus Vaccination Policies and Discourse on Social Media.JAMA health forum · 2026Article
- HPV vaccination coverage, hesitancy, and barriers: Insights from a serial cross-sectional study in Shanghai, China (2019-2024).Human vaccines & immunotherapeutics · 2025Article
- Is the HPV vaccine lottery system equitable under constrained vaccine supply? A cross-sectional study in China.Archives of public health = Archives belges de sante publique · 2025Article
- The Role of Internet Information on Anti-HPV Vaccines: A Comprehensive Overview of a Double-Edged Sword.Vaccines · 2025Review
- Behaviors and willingness to support HPV vaccination for women: a cross-sectional study of young adult men in China.BMC public health · 2024Article
- The role of personal health beliefs and altruistic beliefs in young Chinese adult men's acceptance of the human papillomavirus vaccine.Scientific reports · 2024Article
- Inequities in human papillomavirus vaccination among children aged 9-14 years old under constrained vaccine supply in China.International journal for equity in health · 2024Article
- Reporting of Ethical Considerations in Qualitative Research Utilizing Social Media Data on Public Health Care: Scoping Review.Journal of medical Internet research · 2024Article
- Government-Nongovernmental Organization (NGO) Collaboration in Macao's COVID-19 Vaccine Promotion: Social Media Case Study.JMIR infodemiology · 2024Article
- Between now and later: a mixed methods study of HPV vaccination delay among Chinese caregivers in urban Chengdu, China.BMC public health · 2024Article
- Methods for Analyzing the Contents of Social Media for Health Care: Scoping Review.Journal of medical Internet research · 2023Article
- Article
- Investigating Media Coverage and Public Perceptions of the HPV Vaccine in China - A Content Analysis of Weibo Posts.Sexuality & culture · 2023Article
- A study of parental decision-making over the vaccination of girls, based on the protection motivation theory and the elaboration likelihood model.Frontiers in public health · 2022Article
- Media Data and Vaccine Hesitancy: Scoping Review.JMIR infodemiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rather than receive the effective 2vHPV vaccines that are readily available in China, Chinese women usually wait to receive 4v and 9vHPV vaccines, which are difficult to acquire. This means that Chinese women miss the opportunity for optimal protection from cervical cancer. As social media platforms are the main channel by which Chinese women learn about HPV vaccines, this study aimed to explore how HPV vaccines are described on social media, and in particular how they discuss or distinguish 2 v, 4 v and 9vHPV vaccines. The Octopus Web crawler tool was used to capture hot Weibo posts from 2013-2021, and 1,164 valid data were obtained. Results suggested that there are very few posts with great influence on Weibo about HPV vaccines among 9 years and much of them are created by "lay people." HPV-related topics lacked persistent popularity, comprised highly repetitive content and the spread of information was geographically diverse. There were significant differences in the media descriptions of different kinds of HPV vaccines. Price was mentioned more often in the descriptions of 2vHPV vaccines, whereas appointments were referred to most often in the descriptions of 9vHPV vaccines. There was little media attention paid to the safety and effectiveness of HPV vaccines. Chinese media should develop better collaborations with public health professionals, pay more attention to the originality of their news coverage of HPV vaccines and strive to promote HPV vaccination. Such collaboration will help news media to better understand the key points of HPV information that need to be disseminated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.